SAB Biotherapeutics Inc (SABS) — Free Cash Flow Generation Index
SAB Biotherapeutics Inc (SABS) has a Free Cash Flow Generation Index of 85.55x as of December 2022. Free cash flow of $18.54 Million represents 86% of operating cash flow ($216.72K). Explore capital reinvestment ratio of SAB Biotherapeutics Inc to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
SAB Biotherapeutics Inc Free Cash Flow Generation Index (2020–2021)
Historical FCF Generation Index trend for SAB Biotherapeutics Inc across 2 annual periods. For the full cash flow conversion analysis, see cash flow conversion of SAB Biotherapeutics Inc.
Annual Free Cash Flow Generation for SAB Biotherapeutics Inc (2020–2021)
Year-by-year Free Cash Flow Generation Index for SAB Biotherapeutics Inc. Check cash flow reinvestment rate of SAB Biotherapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2021 | -4.51x | $-8.96 Million | $1.99 Million | $10.94 Million | ▼ -1553.9% |
| 2020 | -0.27x | $-2.73 Million | $10.00 Million | $12.73 Million | — |